RenovoRx to Host Fourth Quarter and Full Year 2025 Financial Results and Business Highlights Conference Call on March 30th at 4:30 p.m. ET [Yahoo! Finance]
RenovoRx, Inc. (RNXT)
Company Research
Source: Yahoo! Finance
the “Company”) (Nasdaq: RNXT) , a life sciences company developing innovative targeted oncology therapies and commercializing RenovoCath ® , a patented, FDA-cleared drug-delivery device, today announced that it will host its fourth quarter and full year 2025 financial results and business highlights conference call on March 30, 2026, at 4:30 p.m. ET. Additional details will be available on the Investor Relations section of the Company's website at https://ir.renovorx.com/ On the call, RenovoRx's management team is expected to discuss the continued progress in RenovoCath adoption among U.S. cancer centers, strengthening clinical and commercial momentum. Management will also provide an update on the advancement of RenovoRx's clinical pipeline, including the Phase III TIGeR-PaC clinical trial in locally advanced pancreatic cancer, which remains on track to complete enrollment in the first half of 2026, with final data expected in 2027. The Company will discuss its strategy for genera
Show less
Read more
Impact Snapshot
Event Time:
RNXT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RNXT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RNXT alerts
High impacting RenovoRx, Inc. news events
Weekly update
A roundup of the hottest topics
RNXT
News
- RenovoRx Announces Closing of Oversubscribed $10 Million at Market Private Placement [Yahoo! Finance]Yahoo! Finance
- RenovoRx Announces Closing of Oversubscribed $10 Million at Market Private PlacementGlobeNewswire
- RenovoRx Announces $10 Million at Market Private Placement [Yahoo! Finance]Yahoo! Finance
- RenovoRx announces $10 million private placement [Seeking Alpha]Seeking Alpha
- RenovoRx Announces $10 Million at Market Private PlacementGlobeNewswire
RNXT
Earnings
- 5/15/25 - In-Line
RNXT
Analyst Actions
- 2/17/26 - Ascendiant Capital
RNXT
Sec Filings
- 3/23/26 - Form 8-K
- 2/6/26 - Form 8-K
- 1/30/26 - Form SCHEDULE
- RNXT's page on the SEC website